Segall Bryant & Hamill LLC Has $6.34 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Segall Bryant & Hamill LLC cut its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 1.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 299,438 shares of the company’s stock after selling 4,029 shares during the period. Segall Bryant & Hamill LLC’s holdings in Surgery Partners were worth $6,339,000 at the end of the most recent quarter.

Other hedge funds have also modified their holdings of the company. Natixis Advisors LLC increased its stake in Surgery Partners by 3.0% in the third quarter. Natixis Advisors LLC now owns 12,828 shares of the company’s stock valued at $414,000 after purchasing an additional 376 shares in the last quarter. MeadowBrook Investment Advisors LLC increased its position in shares of Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock valued at $218,000 after buying an additional 1,460 shares in the last quarter. KBC Group NV raised its stake in Surgery Partners by 66.1% during the 4th quarter. KBC Group NV now owns 3,962 shares of the company’s stock worth $84,000 after buying an additional 1,577 shares during the period. Rhumbline Advisers lifted its holdings in Surgery Partners by 1.3% during the fourth quarter. Rhumbline Advisers now owns 121,852 shares of the company’s stock worth $2,580,000 after acquiring an additional 1,588 shares in the last quarter. Finally, Pier Capital LLC increased its holdings in shares of Surgery Partners by 0.5% in the third quarter. Pier Capital LLC now owns 329,882 shares of the company’s stock worth $10,635,000 after acquiring an additional 1,589 shares in the last quarter.

Insider Activity at Surgery Partners

In other Surgery Partners news, insider Marissa Brittenham sold 3,156 shares of the company’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $24.09, for a total transaction of $76,028.04. Following the sale, the insider now directly owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. This represents a 4.74 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO David T. Doherty sold 13,641 shares of Surgery Partners stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.61, for a total transaction of $349,346.01. Following the completion of the transaction, the chief financial officer now directly owns 108,862 shares of the company’s stock, valued at approximately $2,787,955.82. This trade represents a 11.14 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 106,622 shares of company stock valued at $2,717,860. Insiders own 2.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Royal Bank of Canada reiterated an “outperform” rating and set a $35.00 price objective on shares of Surgery Partners in a report on Tuesday. Bank of America assumed coverage on shares of Surgery Partners in a report on Monday, December 16th. They issued a “buy” rating and a $30.00 price target for the company. Macquarie dropped their price objective on shares of Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Finally, JPMorgan Chase & Co. reduced their target price on shares of Surgery Partners from $38.00 to $28.00 and set a “neutral” rating for the company in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $36.63.

Surgery Partners Stock Performance

Shares of SGRY opened at $24.02 on Thursday. The stock has a market capitalization of $3.07 billion, a price-to-earnings ratio of -50.04, a PEG ratio of 19.21 and a beta of 2.73. Surgery Partners, Inc. has a 12 month low of $19.50 and a 12 month high of $33.97. The firm has a fifty day simple moving average of $24.16 and a 200 day simple moving average of $25.64. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Monday, March 3rd. The company reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to the consensus estimate of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. Research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.